98%
921
2 minutes
20
The metastasis of human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSC) is associated with poor prognosis, yet the regulatory mechanisms remain unclear. In this study, we developed a metastasis prediction model using the transcriptomes of 333 HPV-negative HNSC tumor samples, representing one of the largest HPV-negative HNSC sample sets to date. Our model, which leverages miRNA-centered regulatory networks extended by regulome data, showed superior predictive performance with an AUC of 0.805 compared to existing metastasis-related biomarkers. We identified three key miRNAs in our model with significant differential expression in metastatic patients. Notably, miR-27b was downregulated and its target gene FN1 was overexpressed, leading to activation of the cell adhesion pathway. Single-cell RNA-seq analysis confirmed FN1 overexpression specifically in the malignant cells of metastasis patients with HPV-negative HNSC. In vitro, miR-27b was found to reduce metastatic potential by negatively regulating FN1 expression at the translational level. These findings suggest FN1, driven by miR-27b, as a potential driver of metastasis in HPV-negative HNSC, offering new avenues for biomarker development and targeted therapeutic strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316908 | PMC |
http://dx.doi.org/10.1038/s41598-025-08646-3 | DOI Listing |
Sci Rep
July 2025
Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
The metastasis of human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSC) is associated with poor prognosis, yet the regulatory mechanisms remain unclear. In this study, we developed a metastasis prediction model using the transcriptomes of 333 HPV-negative HNSC tumor samples, representing one of the largest HPV-negative HNSC sample sets to date. Our model, which leverages miRNA-centered regulatory networks extended by regulome data, showed superior predictive performance with an AUC of 0.
View Article and Find Full Text PDFNPJ Precis Oncol
February 2025
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Head and neck squamous cell carcinoma (HNSC) is a prevalent malignancy, with HPV-negative tumors exhibiting aggressive behavior and poor prognosis. Understanding the intricate interactions within the tumor microenvironment (TME) is crucial for improving prognostic models and identifying therapeutic targets. Using BulkSignalR, we identified ligand-receptor interactions in HPV-negative TCGA-HNSC cohort (n = 395).
View Article and Find Full Text PDFPLoS One
February 2024
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
Prior to the next generation sequencing and characterization of the tumor genome landscape, mutations in the SWI/SNF chromatin remodeling complex and the KEAP1-NRF2 signaling pathway were underappreciated. While these two classes of mutations appeared to independently contribute to tumor development, recent reports have demonstrated a mechanistic link between these two regulatory mechanisms in specific cancer types and cell models. In this work, we expand upon these data by exploring the relationship between mutations in BAF and PBAF subunits of the SWI/SNF complex and activation of NRF2 signal transduction across many cancer types.
View Article and Find Full Text PDFCureus
December 2023
Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Background Head and neck squamous cell carcinoma (HNSCC) is a prominent global cancer that manifests across diverse sites such as the oral cavity, oropharynx, and larynx. Human papillomavirus (HPV) infection and genetic alterations contribute to HNSCC development. Objective To investigate the complex role of breast carcinoma amplified sequence (BCAS3) in HNSCC pathogenesis.
View Article and Find Full Text PDFJ Stomatol Oral Maxillofac Surg
September 2024
Molecular Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India. Electronic address:
Background/purpose: Dynein Cytoplasmic 1 Intermediate Chain 1 (DYNC1I1) is a crucial cytoplasmic dynein binding component, its high expression levels are associated with malignant progression and poor survival in different types of cancer; however, the oncogenic role of DYNC1I1 in Head and neck squamous cell carcinomas (HNSCC) remains to be elucidated. In our present study, we aimed to explore the potential role of DYNC1I1 expression in the tumorigenesis of HNSCC and the shaping of the immune microenvironment.
Materials And Methods: The expression levels of DYNC1I1 were analyzed in The Cancer Genome Atlas Head-Neck Squamous Cell Carcinoma (TCGA-HNSC) dataset, and then real-time quantitative polymerase chain reaction (RT-qPCR) was used to validate the DYNC1I1 expression in oral squamous cell carcinoma (OSCC) tumor samples, one of the major types of HNSCC.